FIELD: medicine.
SUBSTANCE: invention refers to dermatology, namely prurigo severity prediction. That is ensured by measuring the concentration of venous blood serum in the exacerbation phase β-tryptase and its value of 29±10 mcg/l predicted mild disease course, 71±15 mcg/l – severe clinical course.
EFFECT: invention provides higher accuracy of prurigo severity prediction.
1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR EVALUATING THE EFFECTIVENESS OF TREATING PRURIGO | 2019 |
|
RU2707096C1 |
| METHOD OF EVALUATING THE CLINICAL EFFECTIVENESS OF NUMMULAR MICROBIAL ECZEMA | 2018 |
|
RU2695071C1 |
| METHOD FOR PREDICTING THE TRANSITION OF MODERATELY SEVERE NUMMULAR MICROBIAL ECZEMA TO SEVERE ONE | 2018 |
|
RU2681656C1 |
| METHOD FOR EVALUATING THE EFFECTIVENESS OF A STANDARD THERAPY IN THE PATIENTS WITH NUMULAR MICROBIAL ECZEMA | 2019 |
|
RU2699369C1 |
| METHOD FOR ESTIMATING THE EFFICIENCY OF STANDARD THERAPY AMONG PATIENTS WITH NUMULAR MICROBIAL ECZEMA | 2018 |
|
RU2677881C1 |
| METHOD FOR PREDICTING THE TRANSITION OF THE MEDIUM-HEAVY COURSE OF THE NUMMULAR MICROBIAL ECZEMA INTO THE SEVERE COURSE | 2019 |
|
RU2702236C1 |
| METHOD FOR PREDICTION OF INFILTRATIVE INTO SUPPURATIVE TRANSFORMATION OF ZOOANTROPONOZE TRICHOPHYTIA | 2015 |
|
RU2570377C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE AND EVALUATION OF CLINICAL EFFECTIVENESS OF ATOPIC DERMATITIS TREATMENT | 2015 |
|
RU2603463C1 |
| METHOD FOR ASSESSING THE SEVERITY OF ATOPIC DERMATITIS IN CHILDREN BY OPTICAL COHERENCE TOMOGRAPHY | 2018 |
|
RU2692955C1 |
| METHOD FOR PREDICTING PROBABILITY IN ZOOANTHROPONOSIC TRICHOPHYTOSIS TRANSITION FROM INFILTRATIVE TO PURULENT FORM | 2005 |
|
RU2284038C1 |
